Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Bioline RX Ltd Company Profile (NASDAQ:BLRX)

Consensus Ratings for Bioline RX Ltd (NASDAQ:BLRX) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.33 (226.48% upside)

Analysts' Ratings History for Bioline RX Ltd (NASDAQ:BLRX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/2/2014Roth CapitalInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
5/21/2014AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
5/8/2014Maxim GroupBoost Price TargetBuy$4.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
4/25/2014B. RileyInitiated CoverageBuy$4.00ViewTweet This Rating  Share This Rating on StockTwits
4/25/2014Maxim GroupInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
12/16/2013AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
11/26/2013AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
10/8/2013Roth CapitalBoost Price TargetBuy$3.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
9/9/2013AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
4/19/2013Roth CapitalBoost Price TargetBuy$3.00ViewTweet This Rating  Share This Rating on StockTwits
3/20/2013AegisLower Price TargetBuy$11.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
10/2/2012AegisInitiated CoverageBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2012 forward)